With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

Meanwhile, Jabil’s market share has declined slightly from 5.3% in 2027 to 4.9% in 2024. We noted that Jabil’s revenue in 2024 has experienced the highest decline among competitors ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...

What's Going On With Jabil Shares Friday? Jabil announced that it issued a warrant to Amazon NV Investment Holdings to potentially acquire up to 1,158,539 shares. Dylan Berman Teva Pharmaceutical ...

The manufacturer has been exploring a sale since 2023. STORY HIGHLIGHTS Jabil Inc. acquired Pharmaceutics International Inc. on Feb. 3. Pharmaceutics operates a 360,000-square-foot campus in Hunt ...

Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments.

Jabil (JBL – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Ruplu Bhattacharya from Bank of America Securities reiterated a Buy rating on ...

In this article, we are going to take a look at where Jabil Inc. (NYSE:JBL) stands against the other AI stocks. Artificial intelligence has become a dominant force in the stock market, driving the ...